nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNH1—embryo—ovarian cancer	0.0143	0.0306	CbGeAlD
Dalfampridine—KCNG1—myometrium—ovarian cancer	0.0133	0.0283	CbGeAlD
Dalfampridine—KCNS2—uterus—ovarian cancer	0.0113	0.0242	CbGeAlD
Dalfampridine—KCNG2—testis—ovarian cancer	0.0109	0.0232	CbGeAlD
Dalfampridine—KCND1—embryo—ovarian cancer	0.0106	0.0227	CbGeAlD
Dalfampridine—KCNG1—uterine cervix—ovarian cancer	0.0103	0.022	CbGeAlD
Dalfampridine—KCNS2—female reproductive system—ovarian cancer	0.0102	0.0218	CbGeAlD
Dalfampridine—KCNB1—epithelium—ovarian cancer	0.0101	0.0215	CbGeAlD
Dalfampridine—KCNC3—epithelium—ovarian cancer	0.00978	0.0209	CbGeAlD
Dalfampridine—KCNF1—myometrium—ovarian cancer	0.00945	0.0202	CbGeAlD
Dalfampridine—KCNS1—epithelium—ovarian cancer	0.00905	0.0193	CbGeAlD
Dalfampridine—KCNG1—uterus—ovarian cancer	0.0086	0.0184	CbGeAlD
Dalfampridine—KCNS3—myometrium—ovarian cancer	0.00827	0.0177	CbGeAlD
Dalfampridine—KCNC4—decidua—ovarian cancer	0.00818	0.0175	CbGeAlD
Dalfampridine—KCNF1—uterine cervix—ovarian cancer	0.00735	0.0157	CbGeAlD
Dalfampridine—KCNV2—testis—ovarian cancer	0.00734	0.0157	CbGeAlD
Dalfampridine—KCND2—myometrium—ovarian cancer	0.00721	0.0154	CbGeAlD
Dalfampridine—KCND1—gonad—ovarian cancer	0.0072	0.0154	CbGeAlD
Dalfampridine—KCNF1—decidua—ovarian cancer	0.007	0.015	CbGeAlD
Dalfampridine—KCNH1—testis—ovarian cancer	0.007	0.015	CbGeAlD
Dalfampridine—KCNG1—vagina—ovarian cancer	0.00699	0.0149	CbGeAlD
Dalfampridine—Convulsion—Altretamine—ovarian cancer	0.00691	0.0198	CcSEcCtD
Dalfampridine—KCNF1—endometrium—ovarian cancer	0.00665	0.0142	CbGeAlD
Dalfampridine—KCNA5—uterine cervix—ovarian cancer	0.00658	0.0141	CbGeAlD
Dalfampridine—KCNS3—epithelium—ovarian cancer	0.00649	0.0139	CbGeAlD
Dalfampridine—KCNS3—uterine cervix—ovarian cancer	0.00644	0.0138	CbGeAlD
Dalfampridine—KCND1—female reproductive system—ovarian cancer	0.00643	0.0137	CbGeAlD
Dalfampridine—KCNG1—testis—ovarian cancer	0.00624	0.0133	CbGeAlD
Dalfampridine—KCNH3—testis—ovarian cancer	0.00624	0.0133	CbGeAlD
Dalfampridine—KCNS1—vagina—ovarian cancer	0.00608	0.013	CbGeAlD
Dalfampridine—KCNH8—testis—ovarian cancer	0.00604	0.0129	CbGeAlD
Dalfampridine—KCNQ5—female reproductive system—ovarian cancer	0.00601	0.0128	CbGeAlD
Dalfampridine—KCNC3—testis—ovarian cancer	0.00587	0.0125	CbGeAlD
Dalfampridine—KCNS3—endometrium—ovarian cancer	0.00582	0.0124	CbGeAlD
Dalfampridine—KCND1—vagina—ovarian cancer	0.00582	0.0124	CbGeAlD
Dalfampridine—KCNA5—gonad—ovarian cancer	0.00552	0.0118	CbGeAlD
Dalfampridine—KCNQ5—vagina—ovarian cancer	0.00544	0.0116	CbGeAlD
Dalfampridine—KCNA2—testis—ovarian cancer	0.00543	0.0116	CbGeAlD
Dalfampridine—KCNS1—testis—ovarian cancer	0.00543	0.0116	CbGeAlD
Dalfampridine—KCND2—decidua—ovarian cancer	0.00535	0.0114	CbGeAlD
Dalfampridine—KCNC4—testis—ovarian cancer	0.00519	0.0111	CbGeAlD
Dalfampridine—KCND1—testis—ovarian cancer	0.00519	0.0111	CbGeAlD
Dalfampridine—KCNH7—testis—ovarian cancer	0.00499	0.0107	CbGeAlD
Dalfampridine—KCNQ4—testis—ovarian cancer	0.00499	0.0107	CbGeAlD
Dalfampridine—KCNC1—testis—ovarian cancer	0.00499	0.0107	CbGeAlD
Dalfampridine—KCNF1—vagina—ovarian cancer	0.00498	0.0106	CbGeAlD
Dalfampridine—KCNQ2—gonad—ovarian cancer	0.00497	0.0106	CbGeAlD
Dalfampridine—KCNA5—female reproductive system—ovarian cancer	0.00493	0.0105	CbGeAlD
Dalfampridine—Pharyngolaryngeal pain—Paclitaxel—ovarian cancer	0.00492	0.0141	CcSEcCtD
Dalfampridine—KCNH6—uterus—ovarian cancer	0.0049	0.0105	CbGeAlD
Dalfampridine—KCND3—uterine cervix—ovarian cancer	0.00489	0.0105	CbGeAlD
Dalfampridine—Laryngeal pain—Paclitaxel—ovarian cancer	0.00487	0.014	CcSEcCtD
Dalfampridine—KCNQ3—female reproductive system—ovarian cancer	0.00482	0.0103	CbGeAlD
Dalfampridine—Asthenia—Altretamine—ovarian cancer	0.00467	0.0134	CcSEcCtD
Dalfampridine—KCNQ1—decidua—ovarian cancer	0.00451	0.00965	CbGeAlD
Dalfampridine—KCNA5—female gonad—ovarian cancer	0.00448	0.00958	CbGeAlD
Dalfampridine—Infection—Carboplatin—ovarian cancer	0.00447	0.0128	CcSEcCtD
Dalfampridine—KCNA5—vagina—ovarian cancer	0.00446	0.00952	CbGeAlD
Dalfampridine—KCNQ2—female reproductive system—ovarian cancer	0.00444	0.00949	CbGeAlD
Dalfampridine—KCNH6—female reproductive system—ovarian cancer	0.0044	0.00941	CbGeAlD
Dalfampridine—KCNS3—vagina—ovarian cancer	0.00436	0.00932	CbGeAlD
Dalfampridine—Dizziness—Altretamine—ovarian cancer	0.0043	0.0123	CcSEcCtD
Dalfampridine—Pharyngolaryngeal pain—Docetaxel—ovarian cancer	0.00417	0.012	CcSEcCtD
Dalfampridine—Vomiting—Altretamine—ovarian cancer	0.00414	0.0119	CcSEcCtD
Dalfampridine—KCNA3—lymph node—ovarian cancer	0.00414	0.00884	CbGeAlD
Dalfampridine—Laryngeal pain—Docetaxel—ovarian cancer	0.00413	0.0118	CcSEcCtD
Dalfampridine—KCND3—uterus—ovarian cancer	0.00408	0.00871	CbGeAlD
Dalfampridine—KCNQ2—female gonad—ovarian cancer	0.00404	0.00863	CbGeAlD
Dalfampridine—KCNA5—testis—ovarian cancer	0.00398	0.0085	CbGeAlD
Dalfampridine—KCNA2—lymph node—ovarian cancer	0.00393	0.00841	CbGeAlD
Dalfampridine—KCNS3—testis—ovarian cancer	0.00389	0.00832	CbGeAlD
Dalfampridine—Nausea—Altretamine—ovarian cancer	0.00387	0.0111	CcSEcCtD
Dalfampridine—KCND2—female gonad—ovarian cancer	0.00383	0.00818	CbGeAlD
Dalfampridine—KCNC4—lymph node—ovarian cancer	0.00376	0.00804	CbGeAlD
Dalfampridine—Chest discomfort—Paclitaxel—ovarian cancer	0.00375	0.0108	CcSEcCtD
Dalfampridine—KCNQ2—testis—ovarian cancer	0.00358	0.00766	CbGeAlD
Dalfampridine—KCNQ1—female reproductive system—ovarian cancer	0.00355	0.00759	CbGeAlD
Dalfampridine—KCNQ5—lymph node—ovarian cancer	0.00352	0.00752	CbGeAlD
Dalfampridine—KCND2—testis—ovarian cancer	0.00339	0.00725	CbGeAlD
Dalfampridine—KCNQ1—bone marrow—ovarian cancer	0.00335	0.00716	CbGeAlD
Dalfampridine—KCNQ1—female gonad—ovarian cancer	0.00323	0.0069	CbGeAlD
Dalfampridine—Infestation NOS—Topotecan—ovarian cancer	0.00323	0.00926	CcSEcCtD
Dalfampridine—Infestation—Topotecan—ovarian cancer	0.00323	0.00926	CcSEcCtD
Dalfampridine—Chest discomfort—Docetaxel—ovarian cancer	0.00318	0.00913	CcSEcCtD
Dalfampridine—KCND3—testis—ovarian cancer	0.00296	0.00632	CbGeAlD
Dalfampridine—KCNA5—lymph node—ovarian cancer	0.00288	0.00616	CbGeAlD
Dalfampridine—KCNQ1—testis—ovarian cancer	0.00286	0.00612	CbGeAlD
Dalfampridine—KCNS3—lymph node—ovarian cancer	0.00282	0.00603	CbGeAlD
Dalfampridine—Connective tissue disorder—Melphalan—ovarian cancer	0.00279	0.008	CcSEcCtD
Dalfampridine—Infestation—Vinorelbine—ovarian cancer	0.00276	0.00793	CcSEcCtD
Dalfampridine—Infestation NOS—Vinorelbine—ovarian cancer	0.00276	0.00793	CcSEcCtD
Dalfampridine—Tremor—Chlorambucil—ovarian cancer	0.00266	0.00762	CcSEcCtD
Dalfampridine—Angiopathy—Topotecan—ovarian cancer	0.00263	0.00755	CcSEcCtD
Dalfampridine—Immune system disorder—Topotecan—ovarian cancer	0.00262	0.00751	CcSEcCtD
Dalfampridine—Mediastinal disorder—Topotecan—ovarian cancer	0.00261	0.0075	CcSEcCtD
Dalfampridine—Angioedema—Chlorambucil—ovarian cancer	0.00259	0.00743	CcSEcCtD
Dalfampridine—Immune system disorder—Melphalan—ovarian cancer	0.00256	0.00736	CcSEcCtD
Dalfampridine—Mediastinal disorder—Melphalan—ovarian cancer	0.00256	0.00734	CcSEcCtD
Dalfampridine—Convulsion—Chlorambucil—ovarian cancer	0.00246	0.00705	CcSEcCtD
Dalfampridine—Back pain—Topotecan—ovarian cancer	0.00244	0.007	CcSEcCtD
Dalfampridine—Connective tissue disorder—Vinorelbine—ovarian cancer	0.00244	0.00699	CcSEcCtD
Dalfampridine—Confusional state—Chlorambucil—ovarian cancer	0.00233	0.00669	CcSEcCtD
Dalfampridine—KCNH2—myometrium—ovarian cancer	0.00232	0.00496	CbGeAlD
Dalfampridine—Angioedema—Topotecan—ovarian cancer	0.00231	0.00662	CcSEcCtD
Dalfampridine—Infection—Chlorambucil—ovarian cancer	0.0023	0.00659	CcSEcCtD
Dalfampridine—Angiopathy—Vinorelbine—ovarian cancer	0.00225	0.00646	CcSEcCtD
Dalfampridine—Immune system disorder—Vinorelbine—ovarian cancer	0.00224	0.00643	CcSEcCtD
Dalfampridine—Mediastinal disorder—Vinorelbine—ovarian cancer	0.00223	0.00641	CcSEcCtD
Dalfampridine—Nasopharyngitis—Paclitaxel—ovarian cancer	0.00216	0.00619	CcSEcCtD
Dalfampridine—Chest pain—Topotecan—ovarian cancer	0.00215	0.00616	CcSEcCtD
Dalfampridine—KCND3—lymph node—ovarian cancer	0.00214	0.00458	CbGeAlD
Dalfampridine—Convulsion—Melphalan—ovarian cancer	0.00214	0.00614	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00213	0.00612	CcSEcCtD
Dalfampridine—Chest pain—Melphalan—ovarian cancer	0.0021	0.00604	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00209	0.00599	CcSEcCtD
Dalfampridine—Back pain—Vinorelbine—ovarian cancer	0.00209	0.00599	CcSEcCtD
Dalfampridine—KCNQ1—lymph node—ovarian cancer	0.00208	0.00444	CbGeAlD
Dalfampridine—Anaphylactic shock—Topotecan—ovarian cancer	0.00206	0.00591	CcSEcCtD
Dalfampridine—Infection—Topotecan—ovarian cancer	0.00205	0.00587	CcSEcCtD
Dalfampridine—Dyspepsia—Chlorambucil—ovarian cancer	0.00204	0.00584	CcSEcCtD
Dalfampridine—Nervous system disorder—Topotecan—ovarian cancer	0.00202	0.00579	CcSEcCtD
Dalfampridine—Anaphylactic shock—Melphalan—ovarian cancer	0.00202	0.00579	CcSEcCtD
Dalfampridine—Infection—Melphalan—ovarian cancer	0.002	0.00575	CcSEcCtD
Dalfampridine—Skin disorder—Topotecan—ovarian cancer	0.002	0.00574	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.002	0.00573	CcSEcCtD
Dalfampridine—Angioedema—Vinorelbine—ovarian cancer	0.00197	0.00566	CcSEcCtD
Dalfampridine—Skin disorder—Melphalan—ovarian cancer	0.00196	0.00562	CcSEcCtD
Dalfampridine—Feeling abnormal—Chlorambucil—ovarian cancer	0.00191	0.00547	CcSEcCtD
Dalfampridine—Hypotension—Melphalan—ovarian cancer	0.00188	0.00541	CcSEcCtD
Dalfampridine—Infestation—Paclitaxel—ovarian cancer	0.00186	0.00533	CcSEcCtD
Dalfampridine—Infestation NOS—Paclitaxel—ovarian cancer	0.00186	0.00533	CcSEcCtD
Dalfampridine—Paraesthesia—Topotecan—ovarian cancer	0.00185	0.00531	CcSEcCtD
Dalfampridine—Urticaria—Chlorambucil—ovarian cancer	0.00184	0.00527	CcSEcCtD
Dalfampridine—Chest pain—Vinorelbine—ovarian cancer	0.00184	0.00527	CcSEcCtD
Dalfampridine—Dyspnoea—Topotecan—ovarian cancer	0.00184	0.00527	CcSEcCtD
Dalfampridine—Nasopharyngitis—Docetaxel—ovarian cancer	0.00183	0.00524	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00182	0.00524	CcSEcCtD
Dalfampridine—Dyspepsia—Topotecan—ovarian cancer	0.00181	0.0052	CcSEcCtD
Dalfampridine—Paraesthesia—Melphalan—ovarian cancer	0.00181	0.0052	CcSEcCtD
Dalfampridine—KCNH2—uterine cervix—ovarian cancer	0.00181	0.00386	CbGeAlD
Dalfampridine—Urinary tract infection—Paclitaxel—ovarian cancer	0.00181	0.00518	CcSEcCtD
Dalfampridine—Dyspnoea—Melphalan—ovarian cancer	0.0018	0.00516	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00178	0.0051	CcSEcCtD
Dalfampridine—Dyspepsia—Melphalan—ovarian cancer	0.00177	0.00509	CcSEcCtD
Dalfampridine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00176	0.00505	CcSEcCtD
Dalfampridine—Constipation—Topotecan—ovarian cancer	0.00176	0.00505	CcSEcCtD
Dalfampridine—Infection—Vinorelbine—ovarian cancer	0.00175	0.00502	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00174	0.005	CcSEcCtD
Dalfampridine—Nervous system disorder—Vinorelbine—ovarian cancer	0.00173	0.00496	CcSEcCtD
Dalfampridine—Skin disorder—Vinorelbine—ovarian cancer	0.00171	0.00491	CcSEcCtD
Dalfampridine—Hypersensitivity—Chlorambucil—ovarian cancer	0.0017	0.00489	CcSEcCtD
Dalfampridine—Feeling abnormal—Topotecan—ovarian cancer	0.0017	0.00487	CcSEcCtD
Dalfampridine—Asthenia—Chlorambucil—ovarian cancer	0.00166	0.00476	CcSEcCtD
Dalfampridine—Hypotension—Vinorelbine—ovarian cancer	0.00165	0.00472	CcSEcCtD
Dalfampridine—Connective tissue disorder—Paclitaxel—ovarian cancer	0.00164	0.0047	CcSEcCtD
Dalfampridine—Urticaria—Topotecan—ovarian cancer	0.00164	0.00469	CcSEcCtD
Dalfampridine—KCNH2—endometrium—ovarian cancer	0.00163	0.00349	CbGeAlD
Dalfampridine—Urticaria—Melphalan—ovarian cancer	0.0016	0.0046	CcSEcCtD
Dalfampridine—Paraesthesia—Vinorelbine—ovarian cancer	0.00158	0.00454	CcSEcCtD
Dalfampridine—Infestation—Docetaxel—ovarian cancer	0.00157	0.00452	CcSEcCtD
Dalfampridine—Infestation NOS—Docetaxel—ovarian cancer	0.00157	0.00452	CcSEcCtD
Dalfampridine—Dyspnoea—Vinorelbine—ovarian cancer	0.00157	0.00451	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00152	0.00436	CcSEcCtD
Dalfampridine—Hypersensitivity—Topotecan—ovarian cancer	0.00152	0.00435	CcSEcCtD
Dalfampridine—Angiopathy—Paclitaxel—ovarian cancer	0.00151	0.00434	CcSEcCtD
Dalfampridine—Constipation—Vinorelbine—ovarian cancer	0.00151	0.00432	CcSEcCtD
Dalfampridine—Immune system disorder—Paclitaxel—ovarian cancer	0.00151	0.00432	CcSEcCtD
Dalfampridine—KCNH2—uterus—ovarian cancer	0.00151	0.00322	CbGeAlD
Dalfampridine—Mediastinal disorder—Paclitaxel—ovarian cancer	0.0015	0.00431	CcSEcCtD
Dalfampridine—Hypersensitivity—Melphalan—ovarian cancer	0.00149	0.00426	CcSEcCtD
Dalfampridine—Asthenia—Topotecan—ovarian cancer	0.00148	0.00424	CcSEcCtD
Dalfampridine—Vomiting—Chlorambucil—ovarian cancer	0.00147	0.00422	CcSEcCtD
Dalfampridine—Mental disorder—Paclitaxel—ovarian cancer	0.00146	0.00419	CcSEcCtD
Dalfampridine—Feeling abnormal—Vinorelbine—ovarian cancer	0.00145	0.00417	CcSEcCtD
Dalfampridine—Asthenia—Melphalan—ovarian cancer	0.00145	0.00415	CcSEcCtD
Dalfampridine—Back pain—Paclitaxel—ovarian cancer	0.0014	0.00403	CcSEcCtD
Dalfampridine—Urticaria—Vinorelbine—ovarian cancer	0.0014	0.00402	CcSEcCtD
Dalfampridine—Connective tissue disorder—Docetaxel—ovarian cancer	0.00139	0.00399	CcSEcCtD
Dalfampridine—Nausea—Chlorambucil—ovarian cancer	0.00137	0.00394	CcSEcCtD
Dalfampridine—Dizziness—Topotecan—ovarian cancer	0.00136	0.00391	CcSEcCtD
Dalfampridine—Tremor—Paclitaxel—ovarian cancer	0.00136	0.0039	CcSEcCtD
Dalfampridine—KCNH2—female reproductive system—ovarian cancer	0.00135	0.00289	CbGeAlD
Dalfampridine—Angioedema—Paclitaxel—ovarian cancer	0.00133	0.00381	CcSEcCtD
Dalfampridine—Vomiting—Topotecan—ovarian cancer	0.00131	0.00376	CcSEcCtD
Dalfampridine—Rash—Topotecan—ovarian cancer	0.0013	0.00373	CcSEcCtD
Dalfampridine—Hypersensitivity—Vinorelbine—ovarian cancer	0.0013	0.00372	CcSEcCtD
Dalfampridine—Dermatitis—Topotecan—ovarian cancer	0.0013	0.00372	CcSEcCtD
Dalfampridine—Headache—Topotecan—ovarian cancer	0.00129	0.0037	CcSEcCtD
Dalfampridine—Angiopathy—Docetaxel—ovarian cancer	0.00128	0.00368	CcSEcCtD
Dalfampridine—Vomiting—Melphalan—ovarian cancer	0.00128	0.00368	CcSEcCtD
Dalfampridine—KCNH2—bone marrow—ovarian cancer	0.00128	0.00273	CbGeAlD
Dalfampridine—Immune system disorder—Docetaxel—ovarian cancer	0.00128	0.00366	CcSEcCtD
Dalfampridine—Mediastinal disorder—Docetaxel—ovarian cancer	0.00127	0.00366	CcSEcCtD
Dalfampridine—Rash—Melphalan—ovarian cancer	0.00127	0.00365	CcSEcCtD
Dalfampridine—Dermatitis—Melphalan—ovarian cancer	0.00127	0.00364	CcSEcCtD
Dalfampridine—Asthenia—Vinorelbine—ovarian cancer	0.00126	0.00363	CcSEcCtD
Dalfampridine—Convulsion—Paclitaxel—ovarian cancer	0.00126	0.00361	CcSEcCtD
Dalfampridine—Mental disorder—Docetaxel—ovarian cancer	0.00124	0.00355	CcSEcCtD
Dalfampridine—Chest pain—Paclitaxel—ovarian cancer	0.00124	0.00355	CcSEcCtD
Dalfampridine—Nasopharyngitis—Epirubicin—ovarian cancer	0.00123	0.00354	CcSEcCtD
Dalfampridine—Anxiety—Paclitaxel—ovarian cancer	0.00123	0.00353	CcSEcCtD
Dalfampridine—KCNH2—female gonad—ovarian cancer	0.00123	0.00263	CbGeAlD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00123	0.00352	CcSEcCtD
Dalfampridine—KCNH2—vagina—ovarian cancer	0.00122	0.00262	CbGeAlD
Dalfampridine—Nausea—Topotecan—ovarian cancer	0.00122	0.00351	CcSEcCtD
Dalfampridine—Nausea—Melphalan—ovarian cancer	0.0012	0.00344	CcSEcCtD
Dalfampridine—Confusional state—Paclitaxel—ovarian cancer	0.00119	0.00343	CcSEcCtD
Dalfampridine—Back pain—Docetaxel—ovarian cancer	0.00119	0.00342	CcSEcCtD
Dalfampridine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00118	0.0034	CcSEcCtD
Dalfampridine—Infection—Paclitaxel—ovarian cancer	0.00118	0.00338	CcSEcCtD
Dalfampridine—Dizziness—Vinorelbine—ovarian cancer	0.00116	0.00334	CcSEcCtD
Dalfampridine—Nervous system disorder—Paclitaxel—ovarian cancer	0.00116	0.00333	CcSEcCtD
Dalfampridine—Skin disorder—Paclitaxel—ovarian cancer	0.00115	0.0033	CcSEcCtD
Dalfampridine—Nasopharyngitis—Doxorubicin—ovarian cancer	0.00114	0.00327	CcSEcCtD
Dalfampridine—Vomiting—Vinorelbine—ovarian cancer	0.00112	0.00321	CcSEcCtD
Dalfampridine—Rash—Vinorelbine—ovarian cancer	0.00111	0.00319	CcSEcCtD
Dalfampridine—Dermatitis—Vinorelbine—ovarian cancer	0.00111	0.00318	CcSEcCtD
Dalfampridine—Hypotension—Paclitaxel—ovarian cancer	0.00111	0.00318	CcSEcCtD
Dalfampridine—Headache—Vinorelbine—ovarian cancer	0.0011	0.00317	CcSEcCtD
Dalfampridine—KCNH2—testis—ovarian cancer	0.00109	0.00233	CbGeAlD
Dalfampridine—Insomnia—Paclitaxel—ovarian cancer	0.00107	0.00308	CcSEcCtD
Dalfampridine—Convulsion—Docetaxel—ovarian cancer	0.00107	0.00306	CcSEcCtD
Dalfampridine—Paraesthesia—Paclitaxel—ovarian cancer	0.00106	0.00305	CcSEcCtD
Dalfampridine—Infestation NOS—Epirubicin—ovarian cancer	0.00106	0.00305	CcSEcCtD
Dalfampridine—Infestation—Epirubicin—ovarian cancer	0.00106	0.00305	CcSEcCtD
Dalfampridine—Dyspnoea—Paclitaxel—ovarian cancer	0.00106	0.00303	CcSEcCtD
Dalfampridine—Chest pain—Docetaxel—ovarian cancer	0.00105	0.00301	CcSEcCtD
Dalfampridine—Nausea—Vinorelbine—ovarian cancer	0.00105	0.003	CcSEcCtD
Dalfampridine—Dyspepsia—Paclitaxel—ovarian cancer	0.00104	0.00299	CcSEcCtD
Dalfampridine—CYP2E1—female reproductive system—ovarian cancer	0.00104	0.00223	CbGeAlD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00104	0.00299	CcSEcCtD
Dalfampridine—Urinary tract infection—Epirubicin—ovarian cancer	0.00103	0.00296	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00102	0.00294	CcSEcCtD
Dalfampridine—Constipation—Paclitaxel—ovarian cancer	0.00101	0.00291	CcSEcCtD
Dalfampridine—Confusional state—Docetaxel—ovarian cancer	0.00101	0.00291	CcSEcCtD
Dalfampridine—Anaphylactic shock—Docetaxel—ovarian cancer	0.001	0.00288	CcSEcCtD
Dalfampridine—Infection—Docetaxel—ovarian cancer	0.000998	0.00286	CcSEcCtD
Dalfampridine—Nervous system disorder—Docetaxel—ovarian cancer	0.000985	0.00283	CcSEcCtD
Dalfampridine—Infestation NOS—Doxorubicin—ovarian cancer	0.000983	0.00282	CcSEcCtD
Dalfampridine—Infestation—Doxorubicin—ovarian cancer	0.000983	0.00282	CcSEcCtD
Dalfampridine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000976	0.0028	CcSEcCtD
Dalfampridine—Skin disorder—Docetaxel—ovarian cancer	0.000975	0.0028	CcSEcCtD
Dalfampridine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000955	0.00274	CcSEcCtD
Dalfampridine—Urticaria—Paclitaxel—ovarian cancer	0.000941	0.0027	CcSEcCtD
Dalfampridine—Hypotension—Docetaxel—ovarian cancer	0.000938	0.00269	CcSEcCtD
Dalfampridine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000937	0.00269	CcSEcCtD
Dalfampridine—Insomnia—Docetaxel—ovarian cancer	0.000908	0.00261	CcSEcCtD
Dalfampridine—Paraesthesia—Docetaxel—ovarian cancer	0.000902	0.00259	CcSEcCtD
Dalfampridine—Dyspnoea—Docetaxel—ovarian cancer	0.000895	0.00257	CcSEcCtD
Dalfampridine—Dyspepsia—Docetaxel—ovarian cancer	0.000884	0.00254	CcSEcCtD
Dalfampridine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000873	0.0025	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000867	0.00249	CcSEcCtD
Dalfampridine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000867	0.00249	CcSEcCtD
Dalfampridine—Angiopathy—Epirubicin—ovarian cancer	0.000865	0.00248	CcSEcCtD
Dalfampridine—Immune system disorder—Epirubicin—ovarian cancer	0.000861	0.00247	CcSEcCtD
Dalfampridine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000859	0.00247	CcSEcCtD
Dalfampridine—Constipation—Docetaxel—ovarian cancer	0.000859	0.00246	CcSEcCtD
Dalfampridine—Asthenia—Paclitaxel—ovarian cancer	0.00085	0.00244	CcSEcCtD
Dalfampridine—CYP2E1—testis—ovarian cancer	0.000841	0.0018	CbGeAlD
Dalfampridine—Mental disorder—Epirubicin—ovarian cancer	0.000835	0.0024	CcSEcCtD
Dalfampridine—Feeling abnormal—Docetaxel—ovarian cancer	0.000828	0.00237	CcSEcCtD
Dalfampridine—Back pain—Epirubicin—ovarian cancer	0.000803	0.0023	CcSEcCtD
Dalfampridine—Angiopathy—Doxorubicin—ovarian cancer	0.0008	0.0023	CcSEcCtD
Dalfampridine—Immune system disorder—Doxorubicin—ovarian cancer	0.000797	0.00229	CcSEcCtD
Dalfampridine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000795	0.00228	CcSEcCtD
Dalfampridine—KCNH2—lymph node—ovarian cancer	0.000792	0.00169	CbGeAlD
Dalfampridine—Dizziness—Paclitaxel—ovarian cancer	0.000783	0.00225	CcSEcCtD
Dalfampridine—Mental disorder—Doxorubicin—ovarian cancer	0.000773	0.00222	CcSEcCtD
Dalfampridine—Vomiting—Paclitaxel—ovarian cancer	0.000753	0.00216	CcSEcCtD
Dalfampridine—Rash—Paclitaxel—ovarian cancer	0.000747	0.00214	CcSEcCtD
Dalfampridine—Dermatitis—Paclitaxel—ovarian cancer	0.000746	0.00214	CcSEcCtD
Dalfampridine—Back pain—Doxorubicin—ovarian cancer	0.000743	0.00213	CcSEcCtD
Dalfampridine—Headache—Paclitaxel—ovarian cancer	0.000742	0.00213	CcSEcCtD
Dalfampridine—Hypersensitivity—Docetaxel—ovarian cancer	0.00074	0.00212	CcSEcCtD
Dalfampridine—Asthenia—Docetaxel—ovarian cancer	0.000721	0.00207	CcSEcCtD
Dalfampridine—Convulsion—Epirubicin—ovarian cancer	0.000719	0.00206	CcSEcCtD
Dalfampridine—Chest pain—Epirubicin—ovarian cancer	0.000707	0.00203	CcSEcCtD
Dalfampridine—Anxiety—Epirubicin—ovarian cancer	0.000704	0.00202	CcSEcCtD
Dalfampridine—Nausea—Paclitaxel—ovarian cancer	0.000704	0.00202	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000702	0.00201	CcSEcCtD
Dalfampridine—Confusional state—Epirubicin—ovarian cancer	0.000683	0.00196	CcSEcCtD
Dalfampridine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000677	0.00194	CcSEcCtD
Dalfampridine—Infection—Epirubicin—ovarian cancer	0.000673	0.00193	CcSEcCtD
Dalfampridine—Convulsion—Doxorubicin—ovarian cancer	0.000665	0.00191	CcSEcCtD
Dalfampridine—Nervous system disorder—Epirubicin—ovarian cancer	0.000664	0.00191	CcSEcCtD
Dalfampridine—Dizziness—Docetaxel—ovarian cancer	0.000664	0.00191	CcSEcCtD
Dalfampridine—Skin disorder—Epirubicin—ovarian cancer	0.000658	0.00189	CcSEcCtD
Dalfampridine—Chest pain—Doxorubicin—ovarian cancer	0.000654	0.00188	CcSEcCtD
Dalfampridine—Anxiety—Doxorubicin—ovarian cancer	0.000652	0.00187	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000649	0.00186	CcSEcCtD
Dalfampridine—Vomiting—Docetaxel—ovarian cancer	0.000638	0.00183	CcSEcCtD
Dalfampridine—Rash—Docetaxel—ovarian cancer	0.000633	0.00182	CcSEcCtD
Dalfampridine—Hypotension—Epirubicin—ovarian cancer	0.000633	0.00182	CcSEcCtD
Dalfampridine—Dermatitis—Docetaxel—ovarian cancer	0.000633	0.00182	CcSEcCtD
Dalfampridine—Confusional state—Doxorubicin—ovarian cancer	0.000632	0.00181	CcSEcCtD
Dalfampridine—Headache—Docetaxel—ovarian cancer	0.000629	0.00181	CcSEcCtD
Dalfampridine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000627	0.0018	CcSEcCtD
Dalfampridine—Infection—Doxorubicin—ovarian cancer	0.000623	0.00179	CcSEcCtD
Dalfampridine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000615	0.00176	CcSEcCtD
Dalfampridine—Insomnia—Epirubicin—ovarian cancer	0.000613	0.00176	CcSEcCtD
Dalfampridine—Skin disorder—Doxorubicin—ovarian cancer	0.000609	0.00175	CcSEcCtD
Dalfampridine—Paraesthesia—Epirubicin—ovarian cancer	0.000608	0.00175	CcSEcCtD
Dalfampridine—Dyspnoea—Epirubicin—ovarian cancer	0.000604	0.00173	CcSEcCtD
Dalfampridine—Nausea—Docetaxel—ovarian cancer	0.000596	0.00171	CcSEcCtD
Dalfampridine—Dyspepsia—Epirubicin—ovarian cancer	0.000596	0.00171	CcSEcCtD
Dalfampridine—Hypotension—Doxorubicin—ovarian cancer	0.000586	0.00168	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000585	0.00168	CcSEcCtD
Dalfampridine—Constipation—Epirubicin—ovarian cancer	0.000579	0.00166	CcSEcCtD
Dalfampridine—Insomnia—Doxorubicin—ovarian cancer	0.000567	0.00163	CcSEcCtD
Dalfampridine—Paraesthesia—Doxorubicin—ovarian cancer	0.000563	0.00161	CcSEcCtD
Dalfampridine—Dyspnoea—Doxorubicin—ovarian cancer	0.000559	0.0016	CcSEcCtD
Dalfampridine—Feeling abnormal—Epirubicin—ovarian cancer	0.000558	0.0016	CcSEcCtD
Dalfampridine—Dyspepsia—Doxorubicin—ovarian cancer	0.000552	0.00158	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000541	0.00155	CcSEcCtD
Dalfampridine—Urticaria—Epirubicin—ovarian cancer	0.000538	0.00154	CcSEcCtD
Dalfampridine—Constipation—Doxorubicin—ovarian cancer	0.000536	0.00154	CcSEcCtD
Dalfampridine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000516	0.00148	CcSEcCtD
Dalfampridine—Hypersensitivity—Epirubicin—ovarian cancer	0.000499	0.00143	CcSEcCtD
Dalfampridine—Urticaria—Doxorubicin—ovarian cancer	0.000498	0.00143	CcSEcCtD
Dalfampridine—Asthenia—Epirubicin—ovarian cancer	0.000486	0.00139	CcSEcCtD
Dalfampridine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000462	0.00133	CcSEcCtD
Dalfampridine—Asthenia—Doxorubicin—ovarian cancer	0.00045	0.00129	CcSEcCtD
Dalfampridine—Dizziness—Epirubicin—ovarian cancer	0.000448	0.00129	CcSEcCtD
Dalfampridine—Vomiting—Epirubicin—ovarian cancer	0.000431	0.00124	CcSEcCtD
Dalfampridine—Rash—Epirubicin—ovarian cancer	0.000427	0.00123	CcSEcCtD
Dalfampridine—Dermatitis—Epirubicin—ovarian cancer	0.000427	0.00122	CcSEcCtD
Dalfampridine—Headache—Epirubicin—ovarian cancer	0.000424	0.00122	CcSEcCtD
Dalfampridine—Dizziness—Doxorubicin—ovarian cancer	0.000414	0.00119	CcSEcCtD
Dalfampridine—Nausea—Epirubicin—ovarian cancer	0.000402	0.00115	CcSEcCtD
Dalfampridine—Vomiting—Doxorubicin—ovarian cancer	0.000398	0.00114	CcSEcCtD
Dalfampridine—Rash—Doxorubicin—ovarian cancer	0.000395	0.00113	CcSEcCtD
Dalfampridine—Dermatitis—Doxorubicin—ovarian cancer	0.000395	0.00113	CcSEcCtD
Dalfampridine—Headache—Doxorubicin—ovarian cancer	0.000393	0.00113	CcSEcCtD
Dalfampridine—Nausea—Doxorubicin—ovarian cancer	0.000372	0.00107	CcSEcCtD
Dalfampridine—KCNC2—Metabolism—PPP1CC—ovarian cancer	0.000361	0.00197	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPP1CC—ovarian cancer	0.000361	0.00197	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—BRIP1—ovarian cancer	0.000361	0.00197	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—BRIP1—ovarian cancer	0.000361	0.00197	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—BRIP1—ovarian cancer	0.000361	0.00197	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPP1CC—ovarian cancer	0.000361	0.00197	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000355	0.00193	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00035	0.00191	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.00035	0.00191	CbGpPWpGaD
Dalfampridine—KCNQ3—L1CAM interactions—MAPK1—ovarian cancer	0.000345	0.00188	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—MAPK1—ovarian cancer	0.000345	0.00188	CbGpPWpGaD
Dalfampridine—KCNQ3—L1CAM interactions—EGFR—ovarian cancer	0.000345	0.00188	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—EGFR—ovarian cancer	0.000345	0.00188	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—AKT1—ovarian cancer	0.000343	0.00187	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—BRIP1—ovarian cancer	0.000342	0.00186	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPP1CC—ovarian cancer	0.000342	0.00186	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—MAPK1—ovarian cancer	0.00032	0.00174	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—PTEN—ovarian cancer	0.000316	0.00172	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000288	0.00157	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—MAPK1—ovarian cancer	0.000285	0.00155	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—PTEN—ovarian cancer	0.000276	0.00151	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—MAPK1—ovarian cancer	0.000272	0.00148	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—MAPK1—ovarian cancer	0.000272	0.00148	CbGpPWpGaD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—ovarian cancer	0.000266	0.00145	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MET—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MET—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—HRAS—ovarian cancer	0.000257	0.0014	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6ST—ovarian cancer	0.000252	0.00137	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6ST—ovarian cancer	0.000252	0.00137	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—YAP1—ovarian cancer	0.000242	0.00132	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—YAP1—ovarian cancer	0.000242	0.00132	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—YAP1—ovarian cancer	0.000242	0.00132	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000242	0.00132	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—YAP1—ovarian cancer	0.00023	0.00125	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—HRAS—ovarian cancer	0.000229	0.00125	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—MAPK1—ovarian cancer	0.000228	0.00124	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—MAPK1—ovarian cancer	0.000228	0.00124	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—MAPK1—ovarian cancer	0.000228	0.00124	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—MAPK1—ovarian cancer	0.000222	0.00121	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—HRAS—ovarian cancer	0.000219	0.00119	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—HRAS—ovarian cancer	0.000219	0.00119	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—MAPK1—ovarian cancer	0.000216	0.00118	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—ovarian cancer	0.000216	0.00118	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP2—ovarian cancer	0.000215	0.00117	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP2—ovarian cancer	0.000215	0.00117	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—MAPK1—ovarian cancer	0.000198	0.00108	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—MAPK1—ovarian cancer	0.000198	0.00108	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—IL6—ovarian cancer	0.000198	0.00108	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—FASN—ovarian cancer	0.000197	0.00108	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—FASN—ovarian cancer	0.000197	0.00108	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—FASN—ovarian cancer	0.000197	0.00108	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SLC5A5—ovarian cancer	0.000194	0.00106	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SLC5A5—ovarian cancer	0.000194	0.00106	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SLC5A5—ovarian cancer	0.000194	0.00106	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—MAPK1—ovarian cancer	0.000194	0.00106	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—ovarian cancer	0.000189	0.00103	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—ERBB2—ovarian cancer	0.000188	0.00102	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—ERBB2—ovarian cancer	0.000188	0.00102	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SLC2A1—ovarian cancer	0.000188	0.00102	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SLC2A1—ovarian cancer	0.000188	0.00102	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SLC2A1—ovarian cancer	0.000188	0.00102	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—FASN—ovarian cancer	0.000187	0.00102	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SLC5A5—ovarian cancer	0.000184	0.001	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MET—ovarian cancer	0.000184	0.001	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MET—ovarian cancer	0.000184	0.001	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—HRAS—ovarian cancer	0.000183	0.000998	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—HRAS—ovarian cancer	0.000183	0.000998	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—HRAS—ovarian cancer	0.000183	0.000998	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6ST—ovarian cancer	0.00018	0.00098	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6ST—ovarian cancer	0.00018	0.00098	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP1B1—ovarian cancer	0.00018	0.000979	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP1B1—ovarian cancer	0.00018	0.000979	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP1B1—ovarian cancer	0.00018	0.000979	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—HRAS—ovarian cancer	0.000178	0.000971	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SLC2A1—ovarian cancer	0.000178	0.000968	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—MAPK1—ovarian cancer	0.000175	0.000956	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—HRAS—ovarian cancer	0.000174	0.000946	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—MAPK1—ovarian cancer	0.000173	0.000942	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—IL6—ovarian cancer	0.000173	0.000941	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP1B1—ovarian cancer	0.00017	0.000928	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP9—ovarian cancer	0.000161	0.000879	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP9—ovarian cancer	0.000161	0.000879	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPP2R1A—ovarian cancer	0.000159	0.000869	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPP2R1A—ovarian cancer	0.000159	0.000869	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPP2R1A—ovarian cancer	0.000159	0.000869	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000159	0.000869	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—HRAS—ovarian cancer	0.000159	0.000865	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—HRAS—ovarian cancer	0.000159	0.000865	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—HRAS—ovarian cancer	0.000156	0.000848	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP2—ovarian cancer	0.000153	0.000835	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP2—ovarian cancer	0.000153	0.000835	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP1B1—ovarian cancer	0.000153	0.000832	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000153	0.000831	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPP2R1A—ovarian cancer	0.000151	0.000823	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000151	0.000821	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ABCB1—ovarian cancer	0.000148	0.000807	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ABCB1—ovarian cancer	0.000148	0.000807	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ABCB1—ovarian cancer	0.000148	0.000807	CbGpPWpGaD
Dalfampridine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—ovarian cancer	0.000148	0.000806	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000147	0.000801	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—MAPK1—ovarian cancer	0.000147	0.000801	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—MAPK1—ovarian cancer	0.000147	0.000801	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TYMS—ovarian cancer	0.000145	0.000792	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TYMS—ovarian cancer	0.000145	0.000792	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TYMS—ovarian cancer	0.000145	0.000792	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—ovarian cancer	0.000145	0.000789	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—ovarian cancer	0.000145	0.000789	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—NRAS—ovarian cancer	0.000143	0.00078	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—NRAS—ovarian cancer	0.000143	0.00078	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—HRAS—ovarian cancer	0.000141	0.000767	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ABCB1—ovarian cancer	0.00014	0.000765	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—HRAS—ovarian cancer	0.000139	0.000756	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TYMS—ovarian cancer	0.000138	0.000751	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MAPK3—ovarian cancer	0.000137	0.000747	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MAPK3—ovarian cancer	0.000137	0.000747	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ERBB2—ovarian cancer	0.000134	0.000731	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ERBB2—ovarian cancer	0.000134	0.000731	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MAPK1—ovarian cancer	0.00013	0.000711	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MAPK1—ovarian cancer	0.00013	0.000711	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—EGFR—ovarian cancer	0.00013	0.00071	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—EGFR—ovarian cancer	0.00013	0.00071	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.00013	0.000705	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KRAS—ovarian cancer	0.000123	0.000671	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KRAS—ovarian cancer	0.000123	0.000671	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—HRAS—ovarian cancer	0.000118	0.000643	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—HRAS—ovarian cancer	0.000118	0.000643	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CTNNB1—ovarian cancer	0.000117	0.00064	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CTNNB1—ovarian cancer	0.000117	0.00064	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CAV1—ovarian cancer	0.000117	0.000638	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CAV1—ovarian cancer	0.000117	0.000638	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CAV1—ovarian cancer	0.000117	0.000638	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—ovarian cancer	0.000115	0.000627	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—ovarian cancer	0.000115	0.000627	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CAV1—ovarian cancer	0.000111	0.000605	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CG—ovarian cancer	0.000107	0.000581	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CG—ovarian cancer	0.000107	0.000581	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CG—ovarian cancer	0.000107	0.000581	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—HRAS—ovarian cancer	0.000105	0.00057	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—HRAS—ovarian cancer	0.000105	0.00057	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—ovarian cancer	0.000103	0.000563	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—ovarian cancer	0.000103	0.000563	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—STAT3—ovarian cancer	0.000102	0.000558	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—STAT3—ovarian cancer	0.000102	0.000558	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NRAS—ovarian cancer	0.000102	0.000556	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NRAS—ovarian cancer	0.000102	0.000556	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CG—ovarian cancer	0.000101	0.000551	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6—ovarian cancer	0.0001	0.000546	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6—ovarian cancer	0.0001	0.000546	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAPK3—ovarian cancer	9.78e-05	0.000533	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAPK3—ovarian cancer	9.78e-05	0.000533	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CD—ovarian cancer	9.38e-05	0.000511	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CD—ovarian cancer	9.38e-05	0.000511	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CD—ovarian cancer	9.38e-05	0.000511	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NME2—ovarian cancer	9.31e-05	0.000507	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAPK1—ovarian cancer	9.31e-05	0.000507	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAPK1—ovarian cancer	9.31e-05	0.000507	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EGFR—ovarian cancer	9.31e-05	0.000507	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EGFR—ovarian cancer	9.31e-05	0.000507	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6—ovarian cancer	8.96e-05	0.000488	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CD—ovarian cancer	8.89e-05	0.000485	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KRAS—ovarian cancer	8.79e-05	0.000479	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KRAS—ovarian cancer	8.79e-05	0.000479	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CB—ovarian cancer	8.18e-05	0.000445	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CB—ovarian cancer	8.18e-05	0.000445	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CB—ovarian cancer	8.18e-05	0.000445	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CB—ovarian cancer	7.75e-05	0.000422	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HRAS—ovarian cancer	7.47e-05	0.000407	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HRAS—ovarian cancer	7.47e-05	0.000407	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—MAPK1—ovarian cancer	7.32e-05	0.000399	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6—ovarian cancer	7.15e-05	0.00039	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6—ovarian cancer	7.15e-05	0.00039	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTEN—ovarian cancer	7.07e-05	0.000385	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTEN—ovarian cancer	7.07e-05	0.000385	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTEN—ovarian cancer	7.07e-05	0.000385	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTEN—ovarian cancer	6.7e-05	0.000365	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—ovarian cancer	6.6e-05	0.000359	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—ovarian cancer	6.6e-05	0.000359	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYTB—ovarian cancer	6e-05	0.000327	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—HRAS—ovarian cancer	5.88e-05	0.00032	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPP1CC—ovarian cancer	5.25e-05	0.000286	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—BRIP1—ovarian cancer	5.25e-05	0.000286	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CA—ovarian cancer	4.99e-05	0.000272	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CA—ovarian cancer	4.99e-05	0.000272	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CA—ovarian cancer	4.99e-05	0.000272	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CA—ovarian cancer	4.73e-05	0.000257	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—ovarian cancer	4.07e-05	0.000222	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—ovarian cancer	4.07e-05	0.000222	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—ovarian cancer	4.07e-05	0.000222	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—ovarian cancer	3.86e-05	0.00021	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—YAP1—ovarian cancer	3.52e-05	0.000192	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FASN—ovarian cancer	2.87e-05	0.000156	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC5A5—ovarian cancer	2.82e-05	0.000154	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC2A1—ovarian cancer	2.72e-05	0.000148	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP1B1—ovarian cancer	2.61e-05	0.000142	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	2.32e-05	0.000126	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCB1—ovarian cancer	2.15e-05	0.000117	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TYMS—ovarian cancer	2.11e-05	0.000115	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CAV1—ovarian cancer	1.7e-05	9.27e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CG—ovarian cancer	1.55e-05	8.45e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CD—ovarian cancer	1.36e-05	7.43e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CB—ovarian cancer	1.19e-05	6.47e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTEN—ovarian cancer	1.03e-05	5.59e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	7.24e-06	3.95e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—ovarian cancer	5.92e-06	3.22e-05	CbGpPWpGaD
